KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.95

Validation of novel low-dose CT methods for quantifying bone marrow in the appendicular skeleton of patients with multiple myeloma: initial results from the [18F]FDG PET/CT sub-study of the Phase 3 GMMG-HD7 Trial.

Christos Sachpekidis, Marina Hajiyianni, Martin Grözinger, Maja Piller, Annette Kopp-Schneider, Elias K Mai, Lukas John, Sandra Sauer, Niels Weinhold, Ekaterina Menis, Olof Enqvist, Marc S Raab, Anna Jauch, Lars Edenbrandt, Michael Hundemer, Alexander Brobeil, Johann Jende, Heinz-Peter Schlemmer, Stefan Delorme, Hartmut Goldschmidt, Antonia Dimitrakopoulou-Strauss

Eur J Nucl Med Mol Imaging 53(3) 1509-1520

PMID41032077
PMCIDPMC12860749
DOI10.1007/s00259-025-07599-z
发表日期2025-10-01
入排依据:The report is from a randomized Phase III trial in multiple myeloma with a drug intervention and presents original results. However, it does not include a primary or key secondary time-to-event efficacy endpoint (e.g., OS, PFS, DFS). The outcomes are imaging validation metrics (CT values, SUV, MTV, TLG) and correlation analyses. Therefore, it is not eligible for inclusion in a Kaplan-Meier digitization cohort.
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 3 张 PMC Figure,均未识别为 KM 图:Fig. 1:AI 判定为 other;Fig. 2:非 KM 图;Fig. 3:非 KM 图。
摘要

摘要

PURPOSE: The clinical significance of medullary abnormalities in the appendicular skeleton detected by computed tomography (CT) in patients with multiple myeloma (MM) remains incompletely elucidated. This study aims to validate novel low-dose CT-based methods for quantifying myeloma bone marrow (BM) volume in the appendicular skeleton of MM patients undergoing [1⁸F]FDG PET/CT. MATERIALS AND METHODS: Seventy-two newly diagnosed, transplantation eligible MM patients enrolled in the randomised phase 3 GMMG-HD7 trial underwent whole-body [18F]FDG PET/CT prior to treatment and after induction therapy with either isatuximab plus lenalidomide, bortezomib, and dexamethasone or lenalidomide, bortezomib, and dexamethasone alone. Two CT-based methods using the Medical Imaging Toolkit (MITK 2.4.0.0, Heidelberg, Germany) were used to quantify BM infiltration in the appendicular skeleton: (1) Manual approach, based on calculation of the highest mean CT value (CTv) within bony canals. (2) Semi-automated approach, based on summation of CT values across the appendicular skeleton to compute cumulative CT values (cCTv). PET/CT data were analyzed visually and via standardized uptake value (SUV) metrics, applying the Italian Myeloma criteria for PET Use (IMPeTUs). Additionally, an AI-based method was used to automatically derive whole-body metabolic tumor volume (MTV) and total lesion glycolysis (TLG) from PET scans. Post-induction, all patients were evaluated for minimal residual disease (MRD) using BM multiparametric flow cytometry. Correlation analyses were performed between imaging data and clinical, histopathological, and cytogenetic parameters, as well as treatment response. Statistical significance was defined as p < 0.05. RESULTS: At baseline, the median CTv (manual) was 26.1 Hounsfield units (HU) and the median cCTv (semi-automated) was 5.5 HU. Both CT-based methods showed weak but significant correlations with disease burden indicators: CTv correlated with BM plasma cell infiltration (r = 0.29; p = 0.02) and β2-microglobulin levels (r = 0.28; p = 0.02), while cCTv correlated with BM plasma cell infiltration (r = 0.25; p = 0.04). Appendicular CT values further demonstrated significant associations with PET-derived parameters. Notably, SUVmax values from the BM of long bones were strongly correlated with both CTv (r = 0.61; p < 0.001) and moderately with cCTv (r = 0.45; p < 0.001). Patients classified as having increased [1⁸F]FDG uptake in the BM (Deauville Score ≥ 4), according to the IMPeTUs criteria, exhibited significantly higher CTv and cCTv values compared to those with Deauville Score <4 (p = 0.002 for both). AI-based analysis of PET data revealed additional weak-to-moderate significant associations, with MTV correlating with CTv (r = 0.32; p = 0.008) and cCTv (r = 0.45; p < 0.001), and TLG showing correlations with CTv (r = 0.36; p = 0.002) and cCTv (r = 0.46; p < 0.001). Following induction therapy, CT values decreased significantly from baseline (median CTv = -13.8 HU, median cCTv = 5.2 HU; p < 0.001 for both), and CTv significantly correlated with SUVmax values from the BM of long bones (r = 0.59; p < 0.001). In parallel, the incidence of follow-up pathological PET/CT scans, SUV values, Deauville Scores, and AI-derived MTV and TLG values showed a significant reduction after therapy (all p < 0.001). No significant differences in CTv, cCTv, or PET-derived metrics were observed between MRD-positive and MRD-negative patients. CONCLUSIONS: Novel CT-based quantification approaches for assessing BM involvement in the appendicular skeleton correlate with key clinical and PET parameters in MM. As low-dose, standardized techniques, they show promise for inclusion in MM imaging protocols, potentially enhancing assessment of disease extent and treatment response.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(3,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Fig. 1A previously untreated male MM patient with, R-ISS stage II, and a BM plasma cell infiltration rate of 76%. The patient received induction therapy with isatuximab in combination with lenalidomide, bortezomib, and dexamethasone. Following induction therapy, the patient achieved a very good partial response (VGPR) according to IMWG criteria, while MRD remained positive. Shown are representative axial CT images at the level of the femora and results from the manual CT-based quantification of BM infiltration in the appendicular skeleton before ( A ) and after ( B ) induction treatment. The highest mean BM CTv decreased from 32.7 HU to -26.6 HU, reflecting a treatment-associated reduction in BM density
非 KM Figure
Fig. 2Representative images from the semi-automated CT-based quantification of BM infiltration in the appendicular skeleton for the same patient as in Fig. 1 . Transaxial and sagittal CT images at the level of the femora are displayed. Three-dimensional volumes of interest (VOIs) were defined to exclude cortical bone (HU >120) and epiphyseal regions, while including the diaphysis and metaphysis. cCTv were calculated for all voxels within the selected regions. In this case, cCTv decreased from 6.70 HU at baseline ( A ) to 4.98 HU following induction treatment ( B ), indicating a reduction in BM density
非 KM Figure
Fig. 3Representative images from the AI-based software tool applied to PET imaging, illustrating automated, volumetric quantification of BM metabolic activity in the same patient shown in Fig. 1 . A marked reduction in whole-body MTV and TLG is observed from baseline ( A ) to follow-up after induction therapy ( B )
非 KM Figure